NXEN Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume63.00
Average Volume (3M)1.81K
Market Cap
$7.08K
Enterprise Value$374.17K
Total Cash (Recent Filing)$8.29K
Total Debt (Recent Filing)$375.38K
Price to Earnings (P/E)―
Beta-2.96
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding70,772,194
10 Day Avg. Volume0
30 Day Avg. Volume1,806
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)-3.22
Price to Sales (P/S)0.00
P/FCF Ratio-18.10
Enterprise Value/Market Cap52.87
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-5.82
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NXEN FAQ
What was Nexien BioPharma Inc’s price range in the past 12 months?
Nexien BioPharma Inc lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Nexien BioPharma Inc’s market cap?
Nexien BioPharma Inc’s market cap is $7.08K.
When is Nexien BioPharma Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nexien BioPharma Inc’s earnings last quarter?
Nexien BioPharma Inc released its earnings results on Nov 14, 2018. The company reported -$0.018 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.018.
Is Nexien BioPharma Inc overvalued?
According to Wall Street analysts Nexien BioPharma Inc’s price is currently Overvalued.
Does Nexien BioPharma Inc pay dividends?
Nexien BioPharma Inc does not currently pay dividends.
What is Nexien BioPharma Inc’s EPS estimate?
Nexien BioPharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nexien BioPharma Inc have?
Nexien BioPharma Inc has 70,772,194 shares outstanding.
What happened to Nexien BioPharma Inc’s price movement after its last earnings report?
Nexien BioPharma Inc reported an EPS of -$0.018 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Nexien BioPharma Inc?
Currently, no hedge funds are holding shares in NXEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nexien BioPharma Inc
Nexien BioPharma, Inc., a pharmaceutical firm headquartered in Glendale, Colorado, concentrates its efforts on the research, advancement, and market introduction of cannabinoid-derived medications. The company utilizes both pre-clinical and clinical development paths to address a variety of diseases, medical conditions, and disorders. It adopted its current name in September 2018, having previously operated as Intiva BioPharma Inc.
Technical Analysis
China Pharma Holdings
―
―
RedHill Biopharma
―
PainReform
―
Shuttle Pharmaceuticals Holdings, Inc.
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.12% Other Institutional Investors
99.88% Public Companies and
Individual Investors